Top Research Needs to Help Kids with Lupus
July 5, 2019
A study published last week in Pediatric Rheumatology identified the top priorities for research into lupus in...
Stories & News
National Stay Out of the Sun Day
July 3, 2019
Avoiding the sun is something most people with lupus know they just have to live with. About...
Lupus Research Alliance and Lupus Therapeutics – Leading Voices in Trial Diversity
June 25, 2019
Caroline Donovan, Manager of Patient Engagement at Lupus Research Alliance (LRA) affiliate Lupus Therapeutics (LT) took part...
Skin Molecules Promote Cutaneous Lupus
June 24, 2019
Patients with cutaneous lupus develop rashes because immune cells move into the skin and cause inflammation. With...
Possible Cancer Drug 2DG May Boost Good Immune Cells
June 20, 2019
The investigational drug 2DG, tested as a cancer treatment, shows promise for lupus in new results reported...
NIH Work Co-Supported by LRA May Simplify Lupus Nephritis Monitoring
June 20, 2019
As reported by the National Institutes of Health (NIH), research published by the NIH Accelerating Medicines Partnership (AMP)...
LRA-Supported Discovery Highlighted at EULAR
June 19,2019
Partly funded by the Lupus Research Alliance, new results presented at the European Congress of Rheumatology (EULAR) 2019...
Remember During Men’s Health Month that Men Get Lupus Too
June 20, 2019
Michael Lauria knows only too well that lupus is not just a woman’s disease – he was...
Cyclosporine Worked Faster than Mycophenolate Mofetil or Azathioprine for Lupus Nephritis
June 12, 2019
A study presented at EULAR showed that ongoing maintenance therapy with the immunosuppressive drug cyclosporine helped lower...
Gut Bacteria May Cause Antiphospholipid Syndrome, LRA-Funded Study Shows
June 18, 2019
A common type of bacteria living in the gut may spark a common lupus complication called antiphospholipid...
KZR-616 Shows Promise According to Results Reported at EULAR
Kezar Life Sciences announced positive results from the MISSION Phase 1 study testing the investigational KZR-616 as a treatment...
Stelara® Effective Over One Year and Reduces Severe Flares
Results of two analyses from a Phase 2 study of Stelara® (ustekinumab) in lupus showed the drug’s effectiveness over...